{"id":"oral-amoxicillin","safety":{"commonSideEffects":[{"rate":"5–10","effect":"Diarrhea"},{"rate":"3–5","effect":"Nausea"},{"rate":"1–3","effect":"Rash"},{"rate":"0.1–1","effect":"Allergic reaction / anaphylaxis"},{"rate":"1–3","effect":"Abdominal pain"},{"rate":"1–2","effect":"Vomiting"}]},"_chembl":null,"_dailymed":{"setId":"e5bd9918-b073-c50b-e053-2a95a90aaeb7","title":"AMOXICILLIN/CLAV POT ORAL SUSP POWDER, FOR SUSPENSION [DIRECT_RX]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Amoxicillin is a beta-lactam antibiotic that penetrates bacterial cell walls and irreversibly binds to penicillin-binding proteins (PBPs), preventing the cross-linking of peptidoglycan strands. This disrupts cell wall integrity, leading to bacterial cell lysis and death. It is bactericidal and effective against a broad spectrum of gram-positive and some gram-negative bacteria.","oneSentence":"Amoxicillin inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins and blocking peptidoglycan cross-linking.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:58:38.803Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Bacterial infections caused by susceptible organisms (e.g., otitis media, sinusitis, respiratory tract infections, urinary tract infections, skin infections)"},{"name":"Helicobacter pylori eradication (as part of combination therapy)"}]},"trialDetails":[{"nctId":"NCT07492134","phase":"PHASE2","title":"APLAUD Trial (Antibiotics vs PLacebo for Acute Uncomplicated Diverticulitis)","status":"NOT_YET_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2026-04-01","conditions":"Acute Uncomplicated Diverticulitis","enrollment":100},{"nctId":"NCT06977841","phase":"NA","title":"Tegoprazan-Based Therapies for H. Pylori Eradication: A Randomized Controlled Trial","status":"COMPLETED","sponsor":"Zhongshan Hospital (Xiamen), Fudan University","startDate":"2025-06-10","conditions":"Helicobacter Pylori Eradication, Adverse Reaction","enrollment":640},{"nctId":"NCT05761080","phase":"PHASE4","title":"Fast Track Therapeutic Model in Acute Complicated Appendicitis in Pediatrics","status":"RECRUITING","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2021-04-22","conditions":"Laparoscopic Appendectomy, Complicated Appendicitis, Periappendicular Abscess","enrollment":772},{"nctId":"NCT07485010","phase":"PHASE2","title":"Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial","status":"NOT_YET_RECRUITING","sponsor":"The University of Queensland","startDate":"2027-04","conditions":"Mycobacterium Abscessus Pulmonary Disease, Mycobacterium Abscessus Infection, Non-Tuberculous Mycobacterial (NTM) Infections","enrollment":300},{"nctId":"NCT07483736","phase":"PHASE3","title":"Efficacy of an Empirical Treatment With Amoxicillin-clavulanate (AC) Compared to the Combination Amoxicillin-clavulanate and Ciprofloxacin (AC+C) in the Outpatient Care of Chemotherapy-induced Fever in Adult Haematology Patients.","status":"NOT_YET_RECRUITING","sponsor":"Versailles Hospital","startDate":"2026-03","conditions":"C15.378","enrollment":1526},{"nctId":"NCT06154174","phase":"NA","title":"Choline to Improve Malnutrition and Enhance Cognition","status":"RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2023-12-05","conditions":"Severe Acute Malnutrition, Cognitive Impairment, Wasting","enrollment":1500},{"nctId":"NCT05444439","phase":"NA","title":"Antibiotyping and Prevalence of Virulent Genotypes Among Helicobacter Pylori and Their Impact on Response to Therapy","status":"COMPLETED","sponsor":"Assiut University","startDate":"2024-01-20","conditions":"H Pylori Infection","enrollment":100},{"nctId":"NCT05834036","phase":"PHASE4","title":"Effect of Antibiotics on Enteric Neurons and Glia","status":"COMPLETED","sponsor":"Rockefeller University","startDate":"2023-06-23","conditions":"Antibiotic Enterocolitis","enrollment":10},{"nctId":"NCT06080698","phase":"NA","title":"Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2024-02-22","conditions":"Gram-negative Bacteremia","enrollment":1030},{"nctId":"NCT07457385","phase":"PHASE4","title":"Congenital Syphilis Treatment Trial (CONSISTENT) in Neonates","status":"NOT_YET_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2026-11-01","conditions":"Syphilis, Congenital","enrollment":374},{"nctId":"NCT07451171","phase":"PHASE2","title":"Comparative Efficacy of Antibiotics for Small Intestine Bacterial Overgrowth in Bangladeshi Children","status":"NOT_YET_RECRUITING","sponsor":"University of Virginia","startDate":"2026-04","conditions":"Small Intestine Bacterial Overgrowth","enrollment":60},{"nctId":"NCT06340334","phase":"NA","title":"Efficacy and Safety of Tegoprazan Dual Therapy and Furazolidone-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication: A Prospective, Multicenter, Open-label, Randomized Controlled Clinical Study","status":"COMPLETED","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2024-03-31","conditions":"Helicobacter Pylori Infection, Tegoprazan, Furazolidone","enrollment":400},{"nctId":"NCT06412588","phase":"NA","title":"Dual Therapy With Vonoprazan Plus Amoxicillin or Doxycycline Versus Bismuth Quadruple Therapy for Helicobacter Pylori Eradication.","status":"COMPLETED","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2024-06-15","conditions":"Helicobacter Pylori Infection","enrollment":579},{"nctId":"NCT06076304","phase":"PHASE4","title":"Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute Sinusitis","status":"RECRUITING","sponsor":"Daniel Merenstein","startDate":"2023-11-21","conditions":"Sinus Infection, Acute Sinusitis","enrollment":3720},{"nctId":"NCT06494072","phase":"PHASE4","title":"Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP","status":"RECRUITING","sponsor":"Medical College of Wisconsin","startDate":"2024-08-22","conditions":"Community Acquired Pneumonia in Children","enrollment":236},{"nctId":"NCT07308041","phase":"PHASE1","title":"A Study to Investigate the Effect of Linaprazan Glurate on the Pharmacokinetics of Amoxicillin","status":"COMPLETED","sponsor":"Cinclus Pharma Holding AB","startDate":"2025-11-11","conditions":"Drug Interaction, GERD (Gastroesophageal Reflux Disease), Safety, and Tolerability","enrollment":12},{"nctId":"NCT05398679","phase":"PHASE4","title":"Oral Antimicrobial Treatment vs. Outpatient Parenteral for Infective Endocarditis","status":"RECRUITING","sponsor":"Fundacion Clinic per a la Recerca Biomédica","startDate":"2022-08-17","conditions":"Endocarditis Infective","enrollment":360},{"nctId":"NCT06340724","phase":"PHASE3","title":"Banxiaxiexin Decoction Combined With Vonoprazan-Amoxicillin Dual Therapy in H. Pylori Eradication","status":"COMPLETED","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2024-02-15","conditions":"Helicobacter Pylori Infection","enrollment":104},{"nctId":"NCT02701595","phase":"PHASE3","title":"Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Streptococcus","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2016-02-29","conditions":"Infective Endocarditis","enrollment":324},{"nctId":"NCT06537609","phase":"NA","title":"A Platform Trial for Gram Negative Bloodstream Infections","status":"RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2024-04-24","conditions":"Gram-negative Bacteremia","enrollment":2500},{"nctId":"NCT07382661","phase":"PHASE1","title":"Drug-Drug Interaction Between DW4421 and Amoxicillin/Clarithromycin","status":"NOT_YET_RECRUITING","sponsor":"Daewon Pharmaceutical Co., Ltd.","startDate":"2026-02","conditions":"Healthy Adult Volunteers","enrollment":36},{"nctId":"NCT05100654","phase":"EARLY_PHASE1","title":"Collaborative Urological Prosthetics Investigation Directive Research Group","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Chicago","startDate":"2022-04-22","conditions":"Erectile Dysfunction, Penile Prosthesis Infection","enrollment":800},{"nctId":"NCT07364253","phase":"NA","title":"'Propolis Versus Chlorhexidine Gluconate on Wound Healing After Third Molar Surgery: a Randomized Controlled Trial'","status":"COMPLETED","sponsor":"Ataturk University","startDate":"2021-01-05","conditions":"Third Molar Surgery, Post Operative Analgesia","enrollment":52},{"nctId":"NCT06229288","phase":"PHASE3","title":"Amoxicillin Alone Versus Amoxicillin/Clavulanate for Community-acquired Pneumonia in Patients Aged 65 Years or Older, and Hospitalized in a Non-intensive Care Unit Ward","status":"RECRUITING","sponsor":"Nantes University Hospital","startDate":"2024-04-25","conditions":"Community-acquired Pneumonia","enrollment":326},{"nctId":"NCT06510010","phase":"PHASE2","title":"Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer","status":"RECRUITING","sponsor":"Sixth Affiliated Hospital, Sun Yat-sen University","startDate":"2024-12-31","conditions":"Chemotherapy Effect","enrollment":198},{"nctId":"NCT07352098","phase":"NA","title":"7-day High-Dose Vonoprazan-amoxicillin Dual Therapy Versus 14-day Vonoprazan-amoxicillin Dual Therapy for H. Pylori","status":"NOT_YET_RECRUITING","sponsor":"Yueyue Li","startDate":"2026-02-01","conditions":"Helicobacter","enrollment":290},{"nctId":"NCT05647278","phase":"PHASE4","title":"Tegoprazan-Amoxicillin Dual Therapy vs. Bismuth Quadruple Therapy for H. Pylori Infection (TATH-1)","status":"COMPLETED","sponsor":"Zhang Xiaofeng,MD","startDate":"2023-11-01","conditions":"Helicobacter Pylori Infection","enrollment":370},{"nctId":"NCT02783859","phase":"PHASE4","title":"Hospitalised Pneumonia With Extended Treatment (HOPE) Study","status":"COMPLETED","sponsor":"Menzies School of Health Research","startDate":"2016-06","conditions":"Pneumonia","enrollment":314},{"nctId":"NCT07194824","phase":"NA","title":"A Penicillin Allergy Delabeling Inhospital Model Hospitalized Patients","status":"TERMINATED","sponsor":"Althaia Xarxa Assistencial Universitària de Manresa","startDate":"2024-04-04","conditions":"Allergy Drug, Allergy Penicillin","enrollment":165},{"nctId":"NCT07015736","phase":"PHASE4","title":"Effects of Saccharomyces Boulardii CNCM I-745 on Antibiotic-Associated Perturbation in Children Treated for Acute Respiratory Infections (RESTORE Study)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Eskisehir Osmangazi University","startDate":"2025-08-01","conditions":"Antibiotic Associated Diarrhea, Acute Otitis Media, ACUTE SINUSITIS","enrollment":100},{"nctId":"NCT05079620","phase":"PHASE4","title":"Early Antibiotics After Aspiration in ICU Patients","status":"TERMINATED","sponsor":"UConn Health","startDate":"2021-11-30","conditions":"Aspiration, Aspiration Pneumonia","enrollment":5},{"nctId":"NCT07306988","phase":"PHASE4","title":"Eradication of Helicobacter Pylori Improves Metabolic Syndrome Through Modulation of Gut Microbiota.","status":"RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2025-04-17","conditions":"HELICOBACTER PYLORI INFECTIONS, Metabolic Syndrome","enrollment":120},{"nctId":"NCT07304882","phase":"PHASE3","title":"A Comparison of Recovery After Impacted Wisdom Tooth Removal","status":"COMPLETED","sponsor":"University of Science and Technology, Yemen","startDate":"2023-11-30","conditions":"Impacted Mandibular Third Molar Extraction, Post Operative Complications","enrollment":24},{"nctId":"NCT02281929","phase":"PHASE3","title":"Efficacy of Antibiotic Therapy in Severe Alcoholic Hepatitis Treated With Prednisolone","status":"COMPLETED","sponsor":"University Hospital, Lille","startDate":"2015-06-13","conditions":"Alcoholic Hepatitis, Alcoholic Liver Disease","enrollment":297},{"nctId":"NCT01388413","phase":"PHASE4","title":"Safety and Efficacy of a Weekly Oral Cyclic Antibiotic Programme in the Prevention of Urinary Tract Infection on Neurological Bladder","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2011-08","conditions":"Neurogenic Bladder, Urinary Tract Infection","enrollment":45},{"nctId":"NCT07183462","phase":"PHASE4","title":"Azithromycin and Ampicillin for Late PPROM","status":"RECRUITING","sponsor":"Sheba Medical Center","startDate":"2025-09-10","conditions":"Pregnancy Complications, Infectious, Premature Birth, Neonatal Diseases and Abnormalities","enrollment":311},{"nctId":"NCT07236944","phase":"PHASE4","title":"Pivmecillinam as Oral Step-Down Treatment for Escherichia Coli Febrile Urinary Tract Infection Versus Standard of Care","status":"RECRUITING","sponsor":"Uppsala University","startDate":"2025-12","conditions":"Febrile Urinary Tract Infection","enrollment":560},{"nctId":"NCT06869850","phase":"NA","title":"Milk Fat Globule Membrane-Enhanced RUTF for Children With Severe Acute Malnutrition","status":"RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2025-09-22","conditions":"Severe Acute Malnutrition, Cognitive Impairment, Kwashiorkor","enrollment":1600},{"nctId":"NCT06294600","phase":"PHASE3","title":"Clarithromycin Treatment to Prevent Sepsis Progression in CAP (REACT)","status":"RECRUITING","sponsor":"Hellenic Institute for the Study of Sepsis","startDate":"2024-02-12","conditions":"Community-acquired Pneumonia","enrollment":330},{"nctId":"NCT02779179","phase":"NA","title":"Therapeutic Management of Periodontitis and Clinical Manifestations of Rheumatoid Arthritis","status":"COMPLETED","sponsor":"University Hospital, Toulouse","startDate":"2010-11","conditions":"Periodontitis, Rheumatoid Arthritis","enrollment":22},{"nctId":"NCT07275580","phase":"PHASE4","title":"Antibiotic Prophylaxis After Simple Tooth Extraction in Immunosuppressed Patients With Autoimmune Rheumatic Diseases","status":"NOT_YET_RECRUITING","sponsor":"University of Sao Paulo General Hospital","startDate":"2026-01-10","conditions":"Autoimmune Rheumatic Diseases, Tooth Extraction, Infection Prevention","enrollment":352},{"nctId":"NCT07269171","phase":"NA","title":"The Effect of Supplementary Foods Containing Trypsin, Chymotrypsin and Serratia Peptidase on Healing After Impacted Wisdom Tooth Surgery","status":"NOT_YET_RECRUITING","sponsor":"Saglik Bilimleri Universitesi","startDate":"2025-12-01","conditions":"Oral Health Care","enrollment":15},{"nctId":"NCT06751121","phase":"PHASE3","title":"Study to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pylori","status":"COMPLETED","sponsor":"Daewoong Pharmaceutical Co. LTD.","startDate":"2024-02-06","conditions":"Helicobacter Pylori Infection, Helicobacter Pylori Infected Patients, Helicobacter Pylori Infected Subjects","enrollment":461},{"nctId":"NCT06734260","phase":"PHASE3","title":"Optimization of Keverprazan-amoxicillin Dual Therapy for Eradicating Helicobacter Pylori Infection","status":"RECRUITING","sponsor":"Eighth Affiliated Hospital, Sun Yat-sen University","startDate":"2024-09-10","conditions":"Helicobacter Pylori Eradication Rate","enrollment":477},{"nctId":"NCT06823154","phase":"PHASE1","title":"The Implementation and Impact of an Allergy De-Labeling Program in the Emergency Department","status":"ENROLLING_BY_INVITATION","sponsor":"The Hospital for Sick Children","startDate":"2023-11-27","conditions":"Allergy Amoxicillin, Beta-lactam Allergy Labels","enrollment":500},{"nctId":"NCT07234448","phase":"NA","title":"Evaluation of the Use of a Probiotic Containing Bifidobacterium Breve PRL2020 in Oral Drops in Preventing Side Effects From Amoxicillin or Amoxicillin/Clavulanic Acid Antibiotic Use","status":"NOT_YET_RECRUITING","sponsor":"Liaquat University of Medical & Health Sciences","startDate":"2025-12-01","conditions":"Antibiotic-associated Diarrhea","enrollment":1000},{"nctId":"NCT06126731","phase":"PHASE1, PHASE2","title":"Combination Study of Antibiotics With Enzalutamide (PROMIZE)","status":"RECRUITING","sponsor":"Institute of Cancer Research, United Kingdom","startDate":"2023-11-02","conditions":"Metastatic Castration-Resistant Prostate Cancer (mCRPC)","enrollment":39},{"nctId":"NCT07242456","phase":"PHASE2, PHASE3","title":"Head-to-head Study of Tegoprazan 50 mg BID Plus Amoxicillin 1 g TID vs. Vonoprazan 20 mg BID Plus Amoxicillin 1 g TID for H. Pylori Eradication","status":"RECRUITING","sponsor":"First People's Hospital of Hangzhou","startDate":"2025-02-17","conditions":"Helicobacter Pylori Infection","enrollment":240},{"nctId":"NCT07242443","phase":"PHASE4","title":"Tegoprazan Plus Amoxicillin BID vs TID Regimens for H. Pylori Eradication（Frequency Adjusted Same-dose Therapy for H. Pylori）","status":"NOT_YET_RECRUITING","sponsor":"First People's Hospital of Hangzhou","startDate":"2025-11-20","conditions":"HELICOBACTER PYLORI INFECTIONS","enrollment":240},{"nctId":"NCT07233733","phase":"NA","title":"A Clinical Study of Connective Tissue Graft and Enamel Matrix Derivative in the Treatment of Intrabony Periodontal Defects","status":"COMPLETED","sponsor":"Phạm Đình Thiên Khải","startDate":"2024-06-01","conditions":"Periodontal Diseases, Regeneration","enrollment":17},{"nctId":"NCT05846399","phase":"PHASE4","title":"CAT BITE Antibiotic Prophylaxis for the Hand/Forearm (CATBITE)","status":"RECRUITING","sponsor":"University of Missouri-Columbia","startDate":"2023-09-07","conditions":"Cat Bite, Hand Injuries, Arm Injury","enrollment":72},{"nctId":"NCT06010719","phase":"PHASE4","title":"Azithromycin as Adjunctive Treatment for Uncomplicated Severe Acute Malnutrition","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2024-10-23","conditions":"Malnutrition, Child, Severe Acute Malnutrition","enrollment":3000},{"nctId":"NCT07202091","phase":"PHASE2, PHASE3","title":"Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immunoglobulin Stopping or Extension (Stop Ig)","status":"RECRUITING","sponsor":"Monash University","startDate":"2025-05-06","conditions":"Myeloma, Leukemia, Non Hodgkin's Lymphoma","enrollment":900},{"nctId":"NCT01015417","phase":"PHASE3","title":"Place of Antibiotics in the Postoperative Acute Lithiasic Cholecystitis","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2010-05","conditions":"Acute Lithiasic Cholecystitis Grade I or II, Symptoms Lasting for Less Than 5 Days, Required Cholecystectomy","enrollment":414},{"nctId":"NCT06443502","phase":"PHASE3","title":"A Study to Learn About the Safety of Vedolizumab and How Well it Works in Children and Teenagers With Active Chronic Pouchitis","status":"RECRUITING","sponsor":"Takeda","startDate":"2024-11-19","conditions":"Pouchitis","enrollment":30},{"nctId":"NCT06055257","phase":"PHASE3","title":"Combination Therapy: Hyperbaric Oxygen and PENTOCLO for Treatment of Osteoradionecrosis of the Mandible","status":"RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2025-01-16","conditions":"Osteoradionecrosis, Osteoradionecrosis of Jaw, Osteoradionecrosis of the Mandible","enrollment":24},{"nctId":"NCT02707042","phase":"PHASE1","title":"Microbial, Immune, and Metabolic Perturbations by Antibiotics (MIME Study)","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2017-03-22","conditions":"Normal Physiology, Healthy","enrollment":108},{"nctId":"NCT07077122","phase":"NA","title":"Evaluation of the Systemic Burden of Non-surgical Periodontal Therapy: A Randomized Clinical Trial on Five Different Treatment Protocols","status":"RECRUITING","sponsor":"National and Kapodistrian University of Athens","startDate":"2025-08-25","conditions":"Periodontitis","enrollment":75},{"nctId":"NCT07148622","phase":"NA","title":"Effects of Different Antibiotic Regimens in Preterm Premature Rupture of Membranes","status":"COMPLETED","sponsor":"Yuzuncu Yil University","startDate":"2024-10-01","conditions":"Preterm Premature Rupture of Membranes (PPROM), Prophylaxis, Perinatal Outcomes","enrollment":40},{"nctId":"NCT06451913","phase":"PHASE4","title":"Effect of Saccharomyces Boulardii CNCM I-745 on Gut Microbiota in Patients Undergoing Antibiotic Therapy (in the Context of Erythema Migrans (Early Skin Form of Lyme Borreliosis))","status":"RECRUITING","sponsor":"Biocodex","startDate":"2025-07-16","conditions":"Erythema Migrans of Lyme Disease","enrollment":120},{"nctId":"NCT05977868","phase":"PHASE4","title":"Comparing Oral Versus Parenteral Antimicrobial Therapy","status":"TERMINATED","sponsor":"West Virginia University","startDate":"2023-08-04","conditions":"Endovascular Infection, Bone and Joint Infection, Skin and Soft Tissue Infection","enrollment":94},{"nctId":"NCT05464615","phase":"EARLY_PHASE1","title":"Geisinger Antibiotic Allergy Pilot Program: Assess and Address","status":"RECRUITING","sponsor":"Geisinger Clinic","startDate":"2024-03-04","conditions":"Penicillin Allergy","enrollment":100},{"nctId":"NCT05857163","phase":"PHASE3","title":"Efficacy and Safety of Rifasutenizol (TNP 2198), Rabeprazole and Amoxicillin in Participants With H. Pylori Infection","status":"COMPLETED","sponsor":"TenNor Therapeutics (Suzhou) Limited","startDate":"2023-05-18","conditions":"H.Pylori Infection","enrollment":700},{"nctId":"NCT07068607","phase":"PHASE4","title":"Efficacy Comparison of Vonoprazan Combined With Different Antibiotics in Dual Therapy for Helicobacter Pylori Eradication: A Prospective, Randomized Controlled Clinical Trial","status":"RECRUITING","sponsor":"Yongquan Shi","startDate":"2025-04-01","conditions":"Gastritis, Indigestion, Helicobacter Pylori Infection, Gastric Cancer, Peptic Ulcer","enrollment":400},{"nctId":"NCT07104552","phase":"PHASE4","title":"Comparing Short to Standard Amoxicillin Course for Erysipelas","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-01-01","conditions":"Erysipelas","enrollment":656},{"nctId":"NCT06131021","phase":"PHASE3","title":"Shaping the Indications for Periodontal Adjunctive Antibiotics in Dental Practice","status":"RECRUITING","sponsor":"Rutgers, The State University of New Jersey","startDate":"2024-04-25","conditions":"Periodontitis, Periodontal Diseases, Periodontal Pocket","enrollment":150},{"nctId":"NCT06423898","phase":"PHASE4","title":"Ampicillin and Ceftriaxone for the Treatment of Enterococcus Faecalis Infective Endocarditis.","status":"RECRUITING","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2024-10-09","conditions":"Endocarditis, Infective","enrollment":284},{"nctId":"NCT05608564","phase":"NA","title":"Local and Systemic Antimicrobials in Non-surgical Periodontal Therapy","status":"COMPLETED","sponsor":"University of Belgrade","startDate":"2023-01-17","conditions":"Periodontitis","enrollment":38},{"nctId":"NCT06514274","phase":"PHASE4","title":"Study on The Efficacy and Safety of Vonoprazan-containing Berberine Triple Therapy in Helicobacter Pylori First-Line Eradication","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2024-09-20","conditions":"Helicobacter Pylori Infection, Chronic Gastritis","enrollment":558},{"nctId":"NCT06523764","phase":"PHASE4","title":"Efficacy and Safety of Tegoprazan and Minocycline Dual Therapy for Helicobacter Pylori Initial Treatment","status":"ACTIVE_NOT_RECRUITING","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2024-11-11","conditions":"Helicobacter Pylori Infection Chronic Gastrit","enrollment":208},{"nctId":"NCT06168084","phase":"PHASE4","title":"Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy","status":"COMPLETED","sponsor":"Yongquan Shi","startDate":"2023-06-06","conditions":"Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer","enrollment":688},{"nctId":"NCT07040839","phase":"PHASE4","title":"Comparison of Omeprazole vs Vonoprazon in Treatment of H Pylori Infection","status":"NOT_YET_RECRUITING","sponsor":"Rehman Medical Institute - RMI","startDate":"2025-07","conditions":"H Pylori","enrollment":128},{"nctId":"NCT04198129","phase":"PHASE1","title":"The Evaluation of Postoperative Antibiotics in Non-Infected Mandible Fractures","status":"TERMINATED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2020-10-01","conditions":"Jaw Fractures, Infection","enrollment":13},{"nctId":"NCT03479736","phase":"","title":"A Study of Fluoroquinolones Exposure and Collagen-Related Serious Adverse Events","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2017-11-20","conditions":"Retinal Detachment, Achilles Tendon, Aneurysm, Dissecting","enrollment":117911},{"nctId":"NCT02570347","phase":"PHASE4","title":"Routine Antibiotic vs. Directed Antibiotic Treatment in Snake Bite","status":"TERMINATED","sponsor":"Jawaharlal Institute of Postgraduate Medical Education & Research","startDate":"2016-05-03","conditions":"Snake Bites","enrollment":66},{"nctId":"NCT06964334","phase":"PHASE3","title":"The Effect of Vitamin D Supplement as Adjuvant Therapy in Eradication of Helicobacter Pylori Infection","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2025-06-01","conditions":"Helicobacter Pylori Infection","enrollment":70},{"nctId":"NCT06197308","phase":"EARLY_PHASE1","title":"Evaluation of an Oral Microbiota-based Therapeutic as a Treatment Option for PSC","status":"RECRUITING","sponsor":"University of Minnesota","startDate":"2024-03-01","conditions":"Primary Sclerosing Cholangitis","enrollment":28},{"nctId":"NCT06921213","phase":"PHASE2","title":"Comprehensive Ambulatory Antibiotics for the Treatment of Congenital Syphilis","status":"NOT_YET_RECRUITING","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2025-10-01","conditions":"Syphilis, Congenital","enrollment":90},{"nctId":"NCT06303128","phase":"PHASE3","title":"Penicillin Allergy Delabeling After a One-Dose Versus Two-Dose Graded Direct Oral Challenge","status":"RECRUITING","sponsor":"James Tarbox, MD","startDate":"2024-02-03","conditions":"Penicillin Allergy","enrollment":380},{"nctId":"NCT03130452","phase":"PHASE4","title":"Helicobacter Pylori Eradication Study","status":"COMPLETED","sponsor":"Inje University","startDate":"2016-12-17","conditions":"Helicobacter Pylori Infection","enrollment":423},{"nctId":"NCT06953271","phase":"PHASE4","title":"Methenamine Hippurate Following Intradetrusor OnabotulinumtoxinA Injection","status":"NOT_YET_RECRUITING","sponsor":"Women and Infants Hospital of Rhode Island","startDate":"2025-05-15","conditions":"Overactive Bladder (OAB), Urinary Tract Infection (Diagnosis)","enrollment":164},{"nctId":"NCT05345457","phase":"PHASE4","title":"Outpatient Antibiotics Following Previable Rupture of Membranes (pPPROM) Between 18 0/7 and 22 6/7 Weeks Gestational Age","status":"RECRUITING","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2023-01-13","conditions":"Pregnancy Preterm, Pregnancy Prom, PROM, Preterm (Pregnancy)","enrollment":88},{"nctId":"NCT04563325","phase":"PHASE4","title":"Oral-only Antibiotics for Bone and Joint Infections in Children","status":"COMPLETED","sponsor":"Rigshospitalet, Denmark","startDate":"2020-09-15","conditions":"Osteomyelitis, Septic Arthritis, Bone Infection","enrollment":180},{"nctId":"NCT06827496","phase":"","title":"Initial Oral Antibiotics for Bone and Joint Infections in Children","status":"RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2024-11-15","conditions":"Osteomyelitis Acute, Septic Arthritis, Bone Infection","enrollment":100},{"nctId":"NCT06917157","phase":"PHASE4","title":"Latency Antibiotics for Previable Rupture Of Membranes Trial","status":"NOT_YET_RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2025-05-01","conditions":"Preterm Prelabor Rupture of Membranes (PPROM)","enrollment":60},{"nctId":"NCT06906757","phase":"NA","title":"Preterm Rupture of Membranes Optimising Antibiotics Trial","status":"NOT_YET_RECRUITING","sponsor":"University of Melbourne","startDate":"2025-09","conditions":"PPROM, Preterm","enrollment":3900},{"nctId":"NCT06895135","phase":"NA","title":"Comparison of Amoxicillin and Amoxicillin + Clavulanic Acid in Treating Acute Otitis Media in Children","status":"NOT_YET_RECRUITING","sponsor":"University of Health Sciences Lahore","startDate":"2025-05","conditions":"Acute Otitis Media","enrollment":162},{"nctId":"NCT06901375","phase":"EARLY_PHASE1","title":"Zuojin Wan Combined with Vonoprazan-Amoxicillin Dual Therapy in H.Pylori Eradication","status":"NOT_YET_RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2025-05","conditions":"Helicobacter Pylori Infection","enrollment":136},{"nctId":"NCT06877351","phase":"PHASE3","title":"Oral Amoxicillin Compared to Penicillin G Benzathine for the Treatment of Acquired Syphilis.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hospital de Niños R. Gutierrez de Buenos Aires","startDate":"2024-08-14","conditions":"Syphilis Acquired","enrollment":120},{"nctId":"NCT04414722","phase":"EARLY_PHASE1","title":"Mechanisms of Probiotics and Antibiotic-Associated Diarrhea","status":"COMPLETED","sponsor":"Georgetown University","startDate":"2021-01-01","conditions":"Antibiotic-associated Diarrhea","enrollment":118},{"nctId":"NCT05473234","phase":"PHASE3","title":"Azithromycin for Severe Acute Malnutrition in CMAM, Nigeria","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2022-10-06","conditions":"Severe Acute Malnutrition","enrollment":310},{"nctId":"NCT05584683","phase":"PHASE1","title":"A Pharmacokinetic Study of LP-001 in Children With a Bacterial Infection","status":"COMPLETED","sponsor":"Kaizen Bioscience Co.","startDate":"2023-08-09","conditions":"Pediatric, Bacterial Infections","enrollment":39},{"nctId":"NCT04140903","phase":"PHASE4","title":"Partial Oral Antibiotic Treatment for Bacterial Brain Abscess","status":"RECRUITING","sponsor":"Henrik Nielsen","startDate":"2020-11-06","conditions":"Brain Abscess, Cerebral Abscess","enrollment":400},{"nctId":"NCT06787027","phase":"NA","title":"Effect of Manual Massage Technique on Swelling, Pain and Mouth Opening After Bilateral Lower Third Molar Surgery","status":"COMPLETED","sponsor":"Izmir Katip Celebi University","startDate":"2018-03-01","conditions":"Impacted Third Molar Tooth, Swelling/ Edema, Pain","enrollment":46},{"nctId":"NCT06709196","phase":"PHASE4","title":"Clinical Trial Testing Whether Targeted Antibiotic Prophylaxis Can Reduce Infections After Cystectomy Compared to Empiric Prophylaxis","status":"RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2025-01-07","conditions":"Cystectomy, Bladder Cancer Requiring Cystectomy, Postoperative Infections","enrollment":248},{"nctId":"NCT06020716","phase":"PHASE4","title":"Antibiotics, Microbiology and Immunology in Children With Chronic Wet Cough - the AMIC Study","status":"RECRUITING","sponsor":"Helse Stavanger HF","startDate":"2023-08-16","conditions":"Protracted Bacterial Bronchitis","enrollment":350},{"nctId":"NCT03702270","phase":"NA","title":"The Effect of Providing Stratification of Low Risk Penicillin Allergies on Penicillin Allergy Label Removal","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2020-11-11","conditions":"Penicillin Allergy","enrollment":2052},{"nctId":"NCT05830162","phase":"PHASE4","title":"Oral Antibiotics After Obstetric Perineal Tear","status":"COMPLETED","sponsor":"Hanna Jangö","startDate":"2023-03-21","conditions":"Obstetric Trauma, Infections, Wound Dehiscence","enrollment":442},{"nctId":"NCT06533397","phase":"NA","title":"The Application of a Biphasic Calcium Sulfate Graft Material in Sinus Floor Elevation","status":"RECRUITING","sponsor":"Semmelweis University","startDate":"2024-08-24","conditions":"Alveolar Bone Loss, Edentulism Nos","enrollment":40},{"nctId":"NCT06207786","phase":"NA","title":"Nasal Iodine Swab Versus Oral Antibiotic to Prevent Surgical Site Infection After Undergoing Mohs Micrographic Surgery","status":"WITHDRAWN","sponsor":"Mayo Clinic","startDate":"2024-09-01","conditions":"Skin Cancer, Skin Cancer Face, Malignant Cutaneous Adnexal Neoplasm","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":859,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Amoxicillin"],"phase":"marketed","status":"active","brandName":"Oral amoxicillin","genericName":"Oral amoxicillin","companyName":"Boston Medical Center","companyId":"boston-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Amoxicillin inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins and blocking peptidoglycan cross-linking. Used for Bacterial infections caused by susceptible organisms (e.g., otitis media, sinusitis, respiratory tract infections, urinary tract infections, skin infections), Helicobacter pylori eradication (as part of combination therapy), Streptococcal pharyngitis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}